• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

8NE1:GR

4.095 EUR 0.146 3.70%

As of 11:12:38 ET on 09/19/2014.

Snapshot for NeoStem Inc (8NE1)

Open: 3.880 Day's Range: 3.880 - 4.150 Volume: 950
Previous Close: 3.949 52wk Range: 3.152 - 6.823 1-Yr Rtn: -37.22%

Stock Chart for 8NE1

No chart data available.
  • 8NE1:GR 4.095
  • 1D
  • 1M
  • 1Y
3.949
Interactive 8NE1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 8NE1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.5970
Est. PEG Ratio -
Market Cap (M EUR) 144.73
Shares Outstanding (M) 35.34
30 Day Average Volume 1,120
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 8NE1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 8NE1

NeoStem, Inc. develops and manufactures cell therapies. The Company through its subsidiaries offers contract manufacturing services and is developing a cell therapy for the treatment of cardiovascular disease.

Robin L SmithChief Executive OfficerRobert Dickey IVChief Financial Officer
Andrew L PecoraChief Visionary OfficerDouglas W LosordoChief Medical Officer
More Company Profile & Key Executives for 8NE1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil